DMI is engaged in development and sale of pharmaceuticals, medical devices and food supplements manufactured at high-profile plants.
With innovative product portfolio and right partners we have broad access to international and local markets. The gained expertise in the business gives us opportunity to evaluate and determine the needs of people in any given country and wire our resources accordingly.
Our product portfolio ranges from ethical, prescription-driven medicines to OTC products. We work hard to reach new markets and enlarge our portfolio to encompass the needs of nations where we are actively participating in health contribution.

DMI ensures quality of its medicines by providing all information and making timely arrangements, as well as performing thoroughgoing quality control at all stages ranging from the manufacturing to the shipment stages of products. We always look for further expanding and developing our business network, and follow the latest pharmaceutical research and development. We are committed to provide our customers with innovative drugs and make valuable contribution to people’s wellbeing.

DMI partners are expected to carry their activities within law and by exigencies of legislative and non-legislative papers of countries where we are and manage their behaviours according to company policies and principles that we value most. We always make sure that what we offer add value to the respective field and help patients gain back their health. The principles that we hold dearest for our success and future define in general how we are wired to operate. With a culture prone for good flexibility, the principles we have put forward are time-specific and norm of how we work but not rigid and clumsy, and can be changed or adjusted for best not least.